BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2750367)

  • 1. [Changes in hormonal indicators during the treatment of depression of different types].
    Krasnov VI; Kokhanenko EM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):101-5. PubMed ID: 2750367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of intersystemic hormonal interrelations in patients with depression].
    Markova MN; Smirnova LK; Prokhorova IS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):105-10. PubMed ID: 2750368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothalamic-pituitary-end organ function in women with bipolar depression.
    Rasgon NL; Kenna HA; Wong ML; Whybrow PC; Bauer M
    Psychoneuroendocrinology; 2007 Apr; 32(3):279-86. PubMed ID: 17317022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Laboratory diagnosis of depressive disorders].
    Linkowski P
    Rev Med Brux; 1983 Apr; 4(4):229-33. PubMed ID: 6410481
    [No Abstract]   [Full Text] [Related]  

  • 5. ACTH, cortisol and growth hormone 24-hour profiles in major depressive illness.
    Linkowski P; Van Cauter E; Leclercq R; Desmedt D; Brasseur M; Golstein J; Copinschi G; Mendlewicz J
    Acta Psychiatr Belg; 1985; 85(5):615-23. PubMed ID: 3004110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hourly serum cortisol assay over 24hr by immunoenzymology in depression].
    Candito M; Souetre E; Pringuey D; Krebs B; Chambon P; Darcourt G
    Pathol Biol (Paris); 1990 Sep; 38(7):690-3. PubMed ID: 2235083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hormonal profile of depressed patients].
    Lavretskaia EF; Tenidieva VD; Lavretskaia GI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(4):555-8. PubMed ID: 3591135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Towards an attempt at biological differentiation of endogenous and exogenous depression: a study of beta-endorphins and other parameters (prolactin, growth hormone and dexamethasone repression test) in a cohort of ambulatory depressed patients].
    Gallart JM; Galard R; Catalan R; Arguello JM; Castellanos JM; Schwartz S
    Ann Med Psychol (Paris); 1988; 146(8):758-63. PubMed ID: 2977276
    [No Abstract]   [Full Text] [Related]  

  • 9. [Dexamethasone test in the diagnosis and treatment of affective psychoses].
    Evsegneev RA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(4):98-101. PubMed ID: 2750393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopharmaco-endocrinology and depression research].
    Laakmann G
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1988; 46():1-220. PubMed ID: 2831451
    [No Abstract]   [Full Text] [Related]  

  • 11. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recovery on the cortisol circadian rhythm of depressed patients.
    Souêtre E; Salvati E; Rix H; Pringuey D; Krebs B; Ardisson JL; Darcourt G
    Biol Psychiatry; 1988 Jul; 24(3):336-40. PubMed ID: 3401525
    [No Abstract]   [Full Text] [Related]  

  • 13. 24-hour pituitary and adrenal hormone profiles in chronic fatigue syndrome.
    Di Giorgio A; Hudson M; Jerjes W; Cleare AJ
    Psychosom Med; 2005; 67(3):433-40. PubMed ID: 15911907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of a single electroconvulsive shock on pituitary-thyroid-adrenal-gonadal axis function in men with severe depression--preliminary report].
    Motta E; Ostrowska Z; Kazibutowska Z; Paluch M; Płonka J; Gołba A
    Psychiatr Pol; 2005; 39(3):469-79. PubMed ID: 16149757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unipolar-bipolar depressive dichotomy and the relationship between afternoon prolactin and cortisol levels.
    Joyce PR; Sellman JD; Donald RA; Livesey JH; Elder PA
    J Affect Disord; 1988; 14(2):189-93. PubMed ID: 2966833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chronobiological study of melatonin and cortisol secretion in depressed subjects: plasma melatonin, a biochemical marker in major depression.
    Claustrat B; Chazot G; Brun J; Jordan D; Sassolas G
    Biol Psychiatry; 1984 Aug; 19(8):1215-28. PubMed ID: 6498244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Decrease in transcortin binding activity in depression].
    Ktiouet J; de Luca HS; Zouaghi H; Toure-Saw H; Benkelfat C; Loo H
    Encephale; 1984; 10(5):215-6. PubMed ID: 6519016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. I. Analysis of the clinical effect of antidepressive drugs with various pharmacological profiles].
    Twarowska-Hauser J; Strzyzewksi W; Chłopocka-Woźniak M; Markowski S; Nowakowska C; Rajewski A; Rozek B; Sydor L; Zelechowska-Ruda E
    Psychiatr Pol; 1985; 19(5):357-62. PubMed ID: 3913975
    [No Abstract]   [Full Text] [Related]  

  • 19. Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients.
    Watson S; Gallagher P; Smith MS; Young AH; Ferrier IN
    Psychoneuroendocrinology; 2007 Jun; 32(5):464-9. PubMed ID: 17442500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Psychopathological and neurophysiological indicators in endogenous depression and the therapeutic effect of thymoleptics. III. Analysis of the factors affecting the effectiveness of treatment with thymoleptics].
    Twarowska-Hauser J; Strzyzewski W
    Psychiatr Pol; 1985; 19(5):370-5. PubMed ID: 3913977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.